Effects of Neuromuscular Electrical Stimulation on Critically Ill Patients With Mechanical Ventilation
Studieoversikt
Status
Status
Forhold
Forhold
Intervensjon / Behandling
Intervensjon / Behandling
Studietype
Studietype
Registrering (Forventet)
Registrering
Fase
Fase
- Ikke aktuelt
Kontakter og plasseringer
Studiekontakt
Studiekontakt
- Navn: Zehua Dong, Dr.
- Telefonnummer: 86-0532-82919386
- E-post: liuyingwallace@163.com
Studiesteder
-
-
-
Qingdao, Kina, 266003
- Rekruttering
- Neuromuscular electrical stimulation
-
Ta kontakt med:
- Zehua Dong, Dr.
- Telefonnummer: 18661803112
- E-post: liuyingwallace@163.com
-
-
Deltakelseskriterier
Kvalifikasjonskriterier
Kvalifikasjonskriterier
Alder som er kvalifisert for studier
Tar imot friske frivillige
Kjønn som er kvalifisert for studier
Beskrivelse
Inclusion Criteria:
- Prolonged MV(>72 h);
- Written informed consent was obtained from the patients or their relatives
Exclusion Criteria:
- Previous neuromuscular disease;
- Unrelieved pneumothorax, restricted diaphragmatic dyskinesia including abdominal high pressure, a large number of ascites
- Thoracic or diaphragmatic malformation;
- Local skin damage and infection;
- Indwelling a temporary or permanent pacemaker;
- Severe obesity(BMI>35 kg/m2)
- Various reasons (severe intestinal gas accumulation, structural abnormalities) lead to the failure of ultrasonic detection of diaphragm movement;
- Patients with an expected survival time of less than 7 days or with palliative care
Studieplan
Hvordan er studiet utformet?
Designdetaljer
- Primært formål: Behandling
- Tildeling: Randomisert
- Intervensjonsmodell: Parallell tildeling
- Masking: Enkelt
Antall våpen
Våpen og intervensjoner
Deltakergruppe / ArmDeltakergruppe / Arm |
Intervensjon / BehandlingIntervensjon / Behandling |
|---|---|
|
Eksperimentell: NMSE Group
Neuromuscular Electrical Stimulation(NMES) group received consecutive daily sessions of electrical stimulation at specific points starting on the first day of randomization.The subjects also receive conventional physical therapy, which included gross motor therapy and respiratory therapy twice a day every day during their stay in the ICU.
|
NMES was performed using a portable machine.The negative electrodes were placed in the motor points of the following muscles: chest muscles (pectoralis major muscle fibres) and rectus abdominis muscles bilaterally.
A second (positive) electrode was positioned distally to the first, at a site close to the muscle that was being electrically stimulated, totalling 1 channel with 2 electrodes for each muscle .
Each NMES session lasted 30 min.
The following parameters were used: 50 Hz frequency, pulse duration 300 ms, rise time 1 s, stimulus time (ON) 3 s, decay time 1 s, and relaxation time (OFF) 10 s.
Intensity was increased until muscle contraction was visible or could be identified through palpation.
In conscious patients, intensity was adjusted according to their tolerance.
|
|
Ingen inngripen: CPT group
The subjects only receive conventional physical therapy, which included gross motor therapy and respiratory therapy twice a day every day during their stay in the ICU.
|
Hva måler studien?
Primære resultatmål
Primære resultatmål
Resultatmål |
Tiltaksbeskrivelse |
Tidsramme |
|---|---|---|
|
diaphragmatic thickening fraction(DTF)
Tidsramme: baseline,Day 3 of mechanical ventilation,Day 7 of mechanical ventilation,before extubation
|
DTF shows varied thickness of the diaphragm at end-expiration and end-inspiration.
Te maximum and minimum values of each breathing cycle were taken as the end-inspiratory diaphragm thickness (DTei) and the end-expiratory diaphragm thickness (DTee), respectively.
DTF was calculated by DTF=(DTei DTee)/DTee 100%.
Te values for 3 consecutive respiratory cycles were recorded and the average value was taken as the fnal value
|
baseline,Day 3 of mechanical ventilation,Day 7 of mechanical ventilation,before extubation
|
Sekundære resultatmål
Sekundære resultatmål
Resultatmål |
Tiltaksbeskrivelse |
Tidsramme |
|---|---|---|
|
Parasternal Intercostal Muscle Ultrasound
Tidsramme: baseline,Day 3 of mechanical ventilation,Day 7 of mechanical ventilation,before extubation
|
A 10- to 15-MHz linear array transducer was positioned perpendicular to the anterior thorax surface in the longitudinal scan, at the level of the second right intercostal space, approximately 6 to 8 cm lateral to the sternal edge with a window visualizing the second and third ribs. .
Using M-mode, the ultrasound beam was perpendicularly directed at the midsection of the muscle, where it is the thinnest at end-expiration.
The thickness of the parasternal intercostal muscle was measured on frozen images at end expiration and at peak inspiration.
|
baseline,Day 3 of mechanical ventilation,Day 7 of mechanical ventilation,before extubation
|
Andre resultatmål
Andre resultatmål
Resultatmål |
Tidsramme |
|---|---|
|
ventilator-free days at 28 days
Tidsramme: 28 days
|
28 days
|
Samarbeidspartnere og etterforskere
Sponsor
Sponsor
Etterforskere
Etterforskere
- Studieleder: Jinyan Xing, Dr., The Affiliated Hospital of Qingdao University
Studierekorddatoer
Studer hoveddatoer
Studiestart (Faktiske)
Studiestart
Primær fullføring (Forventet)
Primær fullføring
Studiet fullført (Forventet)
Studiet fullført
Datoer for studieregistrering
Først innsendt
Først innsendt
Først innsendt som oppfylte QC-kriteriene
Først innsendt som oppfylte QC-kriteriene
Først lagt ut (Faktiske)
Først lagt ut
Oppdateringer av studieposter
Sist oppdatering lagt ut (Faktiske)
Sist oppdatering lagt ut
Siste oppdatering sendt inn som oppfylte QC-kriteriene
Siste oppdatering sendt inn som oppfylte QC-kriteriene
Sist bekreftet
Sist bekreftet
Mer informasjon
Begreper knyttet til denne studien
Ytterligere relevante MeSH-vilkår
Andre studie-ID-numre
Andre studie-ID-numre
- DZH20220104
Legemiddel- og utstyrsinformasjon, studiedokumenter
Studerer et amerikansk FDA-regulert medikamentprodukt
Studerer et amerikansk FDA-regulert enhetsprodukt
Denne informasjonen ble hentet direkte fra nettstedet clinicaltrials.gov uten noen endringer. Hvis du har noen forespørsler om å endre, fjerne eller oppdatere studiedetaljene dine, vennligst kontakt register@clinicaltrials.gov. Så snart en endring er implementert på clinicaltrials.gov, vil denne også bli oppdatert automatisk på nettstedet vårt. .